Investors focused on the Medical space have likely heard of Avinger (AVGR - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.
Avinger is a member of the Medical sector. This group includes 845 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. AVGR is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for AVGR's full-year earnings has moved 56.70% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that AVGR has returned about 93.33% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 4.33% on average. This shows that Avinger is outperforming its peers so far this year.
Breaking things down more, AVGR is a member of the Medical - Instruments industry, which includes 93 individual companies and currently sits at #108 in the Zacks Industry Rank. On average, this group has gained an average of 11.45% so far this year, meaning that AVGR is performing better in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track AVGR. The stock will be looking to continue its solid performance.